Company Filing History:
Years Active: 2008
Title: The Innovations of Gavin Bernard Lear Harrison
Introduction
Gavin Bernard Lear Harrison is a notable inventor based in Kaitoke, New Zealand. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on addressing nematode infections, which pose challenges in both agricultural and medical contexts.
Latest Patents
Gavin holds a patent for an isolated monoclonal antibody known as mAb PAB-1. This antibody, deposited at ATCC on January 24, 2002, and accorded accession PTA-4005, specifically binds to a surface antigen on nematode L3 larvae. The patent also encompasses the antigen that interacts with the monoclonal antibody, along with its applications in diagnosing, treating, or preventing nematode infections.
Career Highlights
Gavin is associated with Ovita Limited, a company that focuses on innovative solutions in the agricultural sector. His work at Ovita Limited has allowed him to apply his research in practical settings, contributing to advancements in nematode management.
Collaborations
Gavin has collaborated with notable colleagues, including Wayne Robert Hein and Hugh Douglas Pulford. These partnerships have enhanced his research and development efforts, leading to impactful innovations in the field.
Conclusion
Gavin Bernard Lear Harrison's contributions to biotechnology, particularly through his patent on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in the diagnosis and treatment of nematode infections.